Global Long-Acting Injectables Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Long-Acting Injectables Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Market Overview:

The latest research study on the global Long-Acting Injectables market finds that the global Long-Acting Injectables market reached a value of USD 14933.82 million in 2022. It’s expected that the market will achieve USD 24444.84 million by 2028, exhibiting a CAGR of 8.56% during the forecast period.

Segmentation Overview:

By type, Small and Middle Sized Molecule segment accounted for the largest share of market in 2021.

Application Overview:

The market's largest segment by application is the segment Schizophrenia, with a market share of 52.45% in 2021.

Key Companies in the global Long-Acting Injectables market covered in Chapter 3:

Johnson & Johnson
Sanofi
Pfizer
Otsuka
Alkermes
GlaxoSmithKline
Eli Lilly

In Chapter 4 and Chapter 14.2, on the basis of types, the Long-Acting Injectables market from 2018 to 2029 is primarily split into:

Small and Middle Sized Molecule
Large Sized Molecule

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Long-Acting Injectables market from 2018 to 2029 covers:

Schizophrenia

Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)